Oral Health Composition Comprising Purified Biosurfactants and/or Their Derivatives
The present invention provides microbe-based products, as well as methods of their production and use, in oral health compositions. More specifically, the present invention provides materials and methods for enhancing and/or maintaining oral health using topical oral health compositions comprising microbial growth by-products, specifically, biosurfactants.
1 . A composition for enhancing and/or maintaining oral health, the composition comprising one or more purified biosurfactants and, one or more carriers, additives and/or adjuvants; wherein the one or more biosurfactants are glycolipids selected from rhamnolipids (RLP), sophorolipids (SLP), mannosylerythritol lipids (MEL); wherein the biosurfactants are present in the composition at a concentration of about 0.1% to about 5%, and wherein the one or more additives are selected from abrasives, humectants, thickeners, preservatives, fluoride sources, flavoring agents, chelating agents, sweeteners, vitamins, and coloring agents.
2 . A method for enhancing and/or maintaining a subject's oral health, wherein a composition of claim 1 is applied to a surface of the subject's mouth, lips and/or oral cavity.
3 . The method of claim 2 , wherein the surface is selected from teeth, gums, tongue, palate, floor, roof, throat, pharynx, tonsils, cheeks, lips (interior and exterior), and epiglottis.
4 . The method of claim 2 , used to whiten stained teeth.
5 . The method of claim 2 , used to prevent and/or remove oral plaque, biofilm and tartar formation on the surface.
6 . The method of claim 2 , used to reduce the number of undesirable microorganisms in the subject's oral cavity.
7 . The method of claim 6 , wherein the undesirable microorganisms are selected from Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola, Actinobacillus actinomycetemcomitans, Actinomyces naeslundii, Streptococcus mutans, Streptococcus sanguis, Streptococcus cristatus, Streptococcus anginosus, Fusobacterium nucleatum, Candida albicans, Lactobacillus spp., Bifidobacterium spp., Atopobium spp., Veillonella spp., and Campylobacter spp.
8 . The method of claim 2 , used to treat and/or prevent gum disease, gingivitis and periodontal disease.
9 . The method of claim 2 , used to treat and/or prevent halitosis.
10 . The method of claim 2 , used to treat and/or prevent dental caries.
11 . The method of claim 2 , used to treat and/or prevent inflammatory conditions selected from tonsillitis, pharyngitis, laryngitis, glossitis, and stomatitis.
12 . The method of claim 2 , used to enhance healing of open sores and wounds in the oral cavity, said open sores, wounds selected from canker sores, cold sores, cuts, bite wounds, burns, surgical incisions, and tissue trauma.
13 . The method of claim 2 , wherein the subject is a mammal.
14 . The method of claim 13 , wherein the subject is a human or a domesticated animal.